Ginkgo Bioworks Holdings (United States) is listed on the Nasdaq and has a market capitalization of $492.86 million, with shareholders equity totaling $392.64 million.
The company employs approximately 485 people and operates in the Other sector, within the Other industry.
Over the past 12 months, Ginkgo Bioworks Holdings reported $121.30 million in revenue, generating net income of $-251.03 million.
Key financial metrics include a P/E ratio of -1.96, a price-to-book (P/B) ratio of 1.26, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker DNA.